Skip to content

VYCOR MEDICAL, INC.: 10-Q filed 2019-11-12

What VYCOR MEDICAL, INC. reported in its quarterly report filed 2019-11-12 (fiscal Q3 2019): 39 published measures, 103 facts as tagged in accession 0001493152-19-016811.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-12
Fiscal period
fiscal Q3 2019
Accession
0001493152-19-016811 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VYCOR MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-301,085,725USD
At 2018-12-311,043,777USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30-1,266,966USD
At 2019-06-30-1,028,680USD
At 2019-03-31-977,816USD
At 2018-12-31-768,827USD
At 2018-09-30-419,887USD
At 2018-06-30-239,833USD
At 2018-03-31-290,172USD
At 2017-12-3181,442USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-3098,502USD
At 2018-12-3186,481USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-209,609USD92
2019-01-01 to 2019-09-30-575,211USD273
2018-07-01 to 2018-09-30-152,179USD92
2018-01-01 to 2018-09-30-897,399USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-3085,422USD273
2018-01-01 to 2018-09-30-286,132USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-09-3025,057USD273
2018-01-01 to 2018-09-3056,604USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2019-07-01 to 2019-09-30346,308USD92
2019-01-01 to 2019-09-301,126,864USD273
2018-07-01 to 2018-09-30456,213USD92
2018-01-01 to 2018-09-301,082,979USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-49,068USD273
2018-01-01 to 2018-09-30221,473USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-25,057USD273
2018-01-01 to 2018-09-30-56,604USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-29,569,267USD
At 2018-12-31-28,669,686USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-30353,746USD
At 2018-12-31372,641USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-09-30401,440USD273
2018-01-01 to 2018-09-30492,125USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-191,673USD92
2019-01-01 to 2019-09-30-521,797USD273
2018-07-01 to 2018-09-30-132,724USD92
2018-01-01 to 2018-09-30-852,922USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-30655,973USD
At 2018-12-31629,646USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-09-29 to 2012-09-3012,000EUR2

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-302,352,691USD
At 2018-12-311,812,604USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-30198,219USD
At 2018-12-3192,955USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-09-30214,807USD
At 2018-12-31257,468USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-30506,454USD92
2019-01-01 to 2019-09-301,542,027USD273
2018-07-01 to 2018-09-30542,137USD92
2018-01-01 to 2018-09-301,812,771USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-30226,618USD
At 2018-12-31203,122USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30314,781USD92
2019-01-01 to 2019-09-301,020,230USD273
2018-07-01 to 2018-09-30409,413USD92
2018-01-01 to 2018-09-30959,849USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-07-01 to 2019-09-30491,339USD92
2019-01-01 to 2019-09-301,497,016USD273
2018-07-01 to 2018-09-30499,143USD92
2018-01-01 to 2018-09-301,684,445USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3024,752,836shares
At 2018-12-3123,140,694shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-3028,173,146USD
At 2018-12-3127,771,868USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-09-30127,675USD
At 2018-12-31127,673USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-09-3043,586USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-09-3043,586USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-09-306,100USD
At 2018-12-316,000USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-09-30116,046USD
At 2018-12-3182,575USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30209,609USD92
2019-01-01 to 2019-09-30575,211USD273
2018-07-01 to 2018-09-30152,179USD92
2018-01-01 to 2018-09-30897,399USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-371,794USD92
2019-01-01 to 2019-09-30-899,581USD273
2019-04-01 to 2019-06-30-185,304USD91
2019-01-01 to 2019-03-31-342,483USD90
2018-07-01 to 2018-09-30-314,364USD92
2018-01-01 to 2018-09-30-1,221,769USD273
2018-04-01 to 2018-06-30-418,584USD91
2018-01-01 to 2018-03-31-488,821USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-09-3043,376USD273
2018-01-01 to 2018-09-3098,455USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-01-01 to 2019-09-308,983USD273
2018-01-01 to 2018-09-3037,748USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-17,936USD92
2019-01-01 to 2019-09-30-53,414USD273
2018-07-01 to 2018-09-30-19,455USD92
2018-01-01 to 2018-09-30-44,477USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-09-300USD273
2018-01-01 to 2018-09-300USD273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2019-01-01 to 2019-09-300USD273
2018-01-01 to 2018-09-300USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-42,661USD273
2018-01-01 to 2018-09-30134,732USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-3032,914USD273
2018-01-01 to 2018-09-307,565USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30105,205USD273
2018-01-01 to 2018-09-30-45,575USD273

Inspect the source

Entity
VYCOR MEDICAL, INC. / CIK 0001424768
Captured
2026-09-20T08:03:40.055Z
SEC response SHA-256
5a14e6ff2e4ebac913c15e977f951bb2964df57677e781dac80300af4dfd59db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001424768.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))